Natera (NASDAQ: NTRA)
Natera Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Natera Company Info
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
News & Analysis
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Why Natera Stock Is Soaring Today
This DNA testing leader passed the test in Q2.
Should You Buy Natera Stock Despite the Scathing Short-Seller Report From Hindenburg?
The report claims the company's billing practices are deceptive.
This Explosive Biotech Is Taking On a Huge New Market
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics market.
Should You Buy These 2 Prenatal Testing Stocks?
More babies are born in summer and early fall than other times of year, meaning mothers-to-be are likely undergoing prenatal testing now. Can investors profit?
Here's Why Natera Stock Soared 97.6% in the First Half of 2019
Investors are excited about two new products for the genetic testing and liquid biopsy developer.
Here's Why Natera Rose as Much as 24.7% Today
The genetic testing leader announced full-year 2018 operating results, but the numbers were actually pretty poor.
After-Hours News: Kraft Heinz and Natera Are Rising
Here's why these stocks are making moves in after-hours trading.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.